Noninvasix, Inc

Noninvasix, Inc., based in Galveston, TX, is pioneering non-invasive monitoring solutions for central venous oxygenation, a critical indicator of sepsis severity. Their patented optoacoustic platform technology aims to enhance the diagnosis and treatment of tissue hypoxia in critically ill patients within ICU settings.

Focused on addressing the urgent need for early sepsis detection, Noninvasix's innovative monitoring system promises to improve patient outcomes and reduce healthcare costs by enabling timely interventions. Although their technology is not yet FDA approved, its potential applications span various medical contexts, including neonatal care and traumatic brain injuries.

Generated from the website